Will The Rally In Editas Stock Continue After A 20% Rise In A Month?

The stock price of Editas Medicine, a biotechnology company focused on developing treatments using gene editing technology, has seen a rise of over 20% over the last twenty-one trading days, and it is also up a solid 46% over the last ten trading days. The recent rise can be attributed to a wider...